Funds and ETFs AbbVie Inc.

Equities

ABBV

US00287Y1091

Pharmaceuticals

Market Closed - Nyse 16:00:02 2024-05-24 EDT 5-day change 1st Jan Change
157.1 USD -0.76% Intraday chart for AbbVie Inc. -4.56% +1.35%
AbbVie Inc. specializes in therapeutic drug research and development. Its products are intended for treating rheumatoid arthritis, psoriasis, Crohn's disease, thyroid disease, Parkinson's disease, HIV, complications of mucoviscidosis, low testosterone levels, and complications associated with chronic renal disease. Net sales are distributed geographically as follows: the United States (77.1%), Germany (2.3%), Canada (2%), Japan (1.9%), China (1.7%), France (1.4%), Spain ( 0.9%), Italy (0.9%), Australia (0.9%), Brazil (0.8%), United Kingdom (0.8%) and others (9.3%).
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
28
Last Close Price
157.1 USD
Average target price
182.3 USD
Spread / Average Target
+16.05%
Consensus
  1. Stock Market
  2. Equities
  3. ABBV Stock
  4. Funds and ETFs AbbVie Inc.